Munich, Bayern, Germany Munich Re/ERGO Corporate Venture Fund seemed to be an CVC arrangement as part of the organization.
The usual things for fund are deals in the range of more than 100 millions dollars. The typical startup value when the investment from Munich Re/ERGO Corporate Venture Fund is more than 1 billion dollars. The top activity for fund was in 2018. The fund is generally included in less than 2 deals every year.
The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Munich Re/ERGO Corporate Venture Fund, startups are often financed by BMW i Ventures, Penske Automotive Group, Kinnevik AB. The meaningful sponsors for the fund in investment in the same round are Vostok New Ventures, Sony Innovation Fund, SoftBank Investment Advisers. In the next rounds fund is usually obtained by Silicon Valley Bank.
Among the most successful fund investment fields, there are Fleet Management, SaaS. Among the most popular portfolio startups of the fund, we may highlight Babylon Health, Fair, Ridecell. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 2 or 4 of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Besides them, we counted 1 critical employee of this fund in our database.
Related Funds
Funds with similar focus
| Fund Name | Location |
| CIC Partners | Dallas, Texas, United States |
| Eastday.Com | China, Shanghai |
| Felix Capital | England, London, United Kingdom |
| Huahe Capital | Beijing, Beijing, China |
| Human Longevity | California, San Diego, United States |
| Liberty City Ventures | New York, New York, United States |
| NRG Venture Strategies | - |
| Tasrin Investments LTD | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Babylon Health | $550M | 02 Aug 2019 | London, England, United Kingdom | ||
Fair | $385M | 20 Dec 2018 | Santa Monica, California, United States | ||
Ridecell | $28M | 13 Nov 2018 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Babylon Health | $550M | 02 Aug 2019 | London, England, United Kingdom | ||
Fair | $385M | 20 Dec 2018 | Santa Monica, California, United States | ||
Ridecell | $28M | 13 Nov 2018 | San Francisco, California, United States |
